CONGRESS PROGRAM COMMITTEE

Transcription

1 Program Committee Co-Chairs: Andrew Briggs, DPhil University of Glasgow, Glasgow, Scotland Maarten IJzerman, PhD University of Twente, Enschede, The Netherlands CONGRESS PROGRAM COMMITTEE Research Review Committee Co-Chairs: Rok Hren, PhD University of Ljubljana, Ljubljana, Slovenia Margreet G. Franken, PhD Erasmus University Rotterdam, Rotterdam, The Netherlands Andrea Manca University of York, Heslington, York, United Kingdom Ursula Rochau, MD, MSc UMIT - University for Health Sciences, Medical Informatics and Technology, Tirol, Austria Issue Panel Review Committee Co-Chairs: René Allard, PhD Grünenthal GmbH, Aachen, Germany Jan Geissler Patvocates, and European Patients' Academy (EUPATI) Futures Team, Munich, Germany Camilla Palmhøj Nielsen, PhD DEFACTUM, Danish Regions, Public Health & Health Services Research Division, Aarhus N, Denmark Workshop Review Committee Co-Chairs: Raquel Aguiar-Ibáñez, MSc HTA and Observational Research, MSD, Hoddesdon, United Kingdom Martin Scott, MSc Numerus Ltd., Tubingen, Germany Allan Wailoo, PhD University of Sheffield and NICE Decision Support Unit, Sheffield, United Kingdom The following ISPOR members were volunteer reviewers for this Congress. The Program Committee Chairs would like to thank them for their contribution to this Congress.

2 ISSUE PANEL REVIEW COMMITTEE MEMBERS Adrian Levy, PhD, Professor, Dalhousie University, Halifax, Nova Scotia, Canada Akriti Chahar, PhD, Consultant-HTA, National Health Systems Resource Centre, New Delhi, Delhi, India Ambrish Singh, MTech, Specialist-Therapy Access, Abbott, Delhi, India Ana Maria Rodriguez, PhD, Senior Epidemiologist, Psychometrician, QuintilesIMS, Madrid/Montreal, Madrid/Quebec, Spain/Canada Andras Inotai, PhD, PharmD, Assistant Professor & Principal Researcher, Eötvös Loránd University/Syreon Research Institute, Budapest, Hungary Andreas Pleil, PhD, Senior Director, Pfizer, San Diego, CA, Anita Burrell, BA, MA, MBA, Founder & Chief Executive Officer, Anita Burrell Consulting LLC, Flemington, NJ, Anne Marciniak, MD, PhD, Senior Director, Specialty Care Lead, Allergan, Marlow, UK Benoit Arnould, PhD, Senior Director, Global, Patient-Centered Outcomes, Mapi, Lyon, France Bernd Brüggenjürgen, MD, MPH, Head Institute for Health Economics, Steinbeis University Berlin, Berlin, Germany Beth O'Leary, MPH, MSc, Executive Director, Covance Inc., Sydney, NSW, Australia Bineet Gupta, PhD, Associate Professor, Shri Ramswaroop Memorial University, Barabanki, Uttar Pradesh, India Brooke Harrow, PhD, Director, Health Economics and Outcomes Research, TESARO, Inc., Waltham, MA, Bruno Flamion, MD, PhD, Head Strategic Development, Actelion Pharmaceuticals, Allschwil, Switzerland Carla Zema, PhD, Vice President, Precision Health Economics, Los Angeles, CA, Christian Brettschneider, PhD, Junior Scientists Group Leader, Hamburg Center for Health Economics, Hamburg, Germany Cinira Lefevre, PhD, Associate Director, Market Access Lead, Bristol Myers Squibb, Paris, Ile-de- France, France Claudia Nicolay, PhD, Senior Research Scientist, Eli Lilly, Bad Homburg, Hessia, Germany Daniel Dröschel, MSc, Health Economist; HTA Specialist, MArS Market Access & Pricing Strategy GmbH, Lörrach, Baden-Wuerttemberg, Germany Dong-Churl Suh, PhD, Professor & Director, Chung-Ang University, Seoul, South Korea Elena Marusakova, MBA, HO, Researcher & Executive Manager, M&C Consulting Group s.r.o., Lozorno, Slovakia Elio Tanaka, MD, Head, Oncology Audit, ICS / Instituto Curitiba De Saúde, Curitiba, Paraná, Brazil Ellen Murphy, PhD, Head of Insight, Cogora, London, UK Erwin De Cock, MSc, Principal Real-World Evidence & Insights, inventiv Health, Barcelona, Spain Gordon Goodall, PhD, Director Health Economics and Outcomes Research, Edwards Lifesciences, Nyon, Switzerland Gracy Crane, PhD, Senior Scientist, Roche, UK Gwilym Thompson, PhD, Health Economic Lead, Janssen UK, High Wycombe, UK Hanna Gyllensten, PhD, Postdoctoral Researcher, Karolinska Institutet, Stockholm, Sweden Hongbo Yang, PhD, Vice President, Analysis Group In., Boston, MA, Hongbo Yuan, MD, PhD, Scientific Advisor, CADTH, Ottawa, ON, Canada

3 Horacio Capote, MD, Medical Director for Neuropsychiatry, Dent Neurological Institute, Amherst, NY, Isabel Monteiro, Pharm, Manager, Roche, Amadora, Portugal JaeJin An, PhD, Assistant Professor, Western University of Health Sciences, Pomona, CA, James Wu, MSc, MPH, Health Economist, Amgen, Thousand Oaks, CA, Jayashri Sankaranarayanan, MPharm, PhD, Adjunct Faculty, UNMC, Wethersfied, CT, Jeetvan Patel, PhD, Senior Manager, Global Health Economics, Amgen, Thousand Oaks, CA, Jennifer Hanlon, MPH, Associate Director, Study Endpoints, Ironwood Pharmaceuticals, Cambridge, MA, Jennifer Hsiang-Ling Lin, PhD, Associate Director, Janssen, Titusville, NJ, Josephine Mauskopf, PhD, Vice President, Health Economics, RTI Health Solutions, Research Triangle Park, NC, Julia Gaebler, PhD, Vice President, Health Advances, Weston, MA, Karen Lee, MA, Director, Health Economics, CADTH, Ottawa, ON, Canada Karen Smoyer, PhD, Strategic Director, HEOR and Real-World Evidence, Envision Pharma Group, Philadelphia, PA, Katherine Houghton, MSc, Associate Director, Health Economics, RTI Health Solutions, Research Triangle Park, NC, Kellie Meyer, PharmD, MPH, Senior Director, Xcenda, Boston, MA, Laila Rasmy, Compliance Control, Egypt Laura Dormer, BSc, Editorial Director, Future Science Group, London, UK Laura Vinuesa, DVM, MSc, Senior Business Insight Analyst, Decision Resources Group, London, UK Lucas Najun Dubos, MD, MHE, Manager, Roche Argentina, Buenos Aires, Buenos Aires, Argentina Majid Davari, PhD, Academic Member, Tehran University of Medical Sciences, Tehran, Iran Manpreet Sidhu, MBA, PhD, Divisional Principal, ICON, Health Economics, New York, Manuela Joore, PhD, Professor of HTA, Maastricht University Medical Center, Maastricht, Limburg, The Netherlands Marco Soro, PharmD, Corporate Anti-infective Access Lead, Angelini SpA, Rome, Italy Matthew Hankins, BSc, PhD, Senior Research Director, Patient-Centred Outcomes, Mapi, London, UK Maureen Smith, Med, Secretary, Canadian Organization for Rare Disorders, Ottawa, ON, Canada Meghana Chalasani, Operations Research Analyst, U.S. Food and Drug Administration Meindert Boysen, PharmD, Programme Director, NICE, Manchester, UK Michael Cangelosi, MA, MPH, Health Economist, Boston Scientific, Marlborough, MA, Michael Schlander, Head of Division of Health Economics, Germann Cancer Research Center (DKFZ), Heidelberg, Baden-Württemberg, Germany Moacyr Nobre, MD, PhD, Medical Director, Cognos - Educação em Saúde, São Paulo, Brazil Nasuh Buyukkaramikli, PhD, Senior Researcher, Institute for Medical Technology Assessment, Rotterdam, The Netherlands Neil Palmer, BA, Principal Consultant, PDCI Market Access Inc., Ottawa, ON, Canada Oriana Ciani, PhD, Postdoctoral Researcher, University of Exeter Medical School, Exeter, UK Pamela Blumberg, MPH, DPH, Senior Director and Team Lead Real-World Evidence, Xcenda, LLC, Palm Harbor, FL, Pronabesh DasMahapatra, MBBS, MPH, Senior Research Scientist, PatientsLikeMe Inc., Cambridge, MA, Raquel Aguiar-Ibáñez, MSc, Senior Health Economics Manager - Oncology, MSD, Hoddesdon, Hertfordshire, UK

4 Sachin Kamal-Bahl, PhD, Vice President & Head, Innovation Center, Patient & Health Impact, Pfizer Inc., Collegeville, PA, Saskia Knies, PhD, Advisor, National Health Care Institute, Diemen, The Netherlands Stephanie Chen, PHD, Director, Health Economics and Payer Analytics, AstraZeneca, Gaithersburg, MD, Sukyeong Kim, RPh, MPH, PhD, Senior Research Fellow, National Evidence-based Healthcare Collaborating Agency (NECA), Seoul, Korea, South Susanne Michel, MD, Vice President Centre of Excellence Market Access, Evidera, Paris, France Vladimir Zah, PhD(c), Health Economist, ISPOR Serbia, Belgrade, Serbia William Archey, Director Market Access, Roche, Basel, Switzerland Yan Wang, PhD, Health Economist, WG Group, New York,

5 RESEARCH REVIEW COMMITTEE MEMBERS Abdulhakeem Olorukooba, FWACP, Lecturer, Ahmadu Bello University, Zaria, Kaduna, Nigeria Abdulkareem Al-Shami, PhD, Lecturer, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan, Pahang, Malaysia Abhijeet Bhanegaonkar, PhD, MPH, Senior Manager - Global HEOR, Vertex Pharmaceuticals, Boston, MA, Abhishek Kavati, PhD, MBA, MS, Associate Director, Novartis Pharmaceuticals Corporation, East Hanover, NJ, Abiola Oladapo, PhD, Associate Director, Shire, Boston, MA, Adam Smith, PhD, Senior Associate, RB, Hull, East Yorkshire, UK Adina Turcu-Stiolica, PhD, Associate Professor, University of Medicine and Pharmacy of Craiova, Craiova, Romania Ahiaba Monday Clement, MHE, Accountant, ARPON, Abuja, FCT, Nigeria Ahmad Fuad Afdhal, PhD, Director, Center for Socio - Economic Studies in Pharmacy, Tangerang Selatan, Banten, Indonesia Ahmed Nouri, DPharm, Universiti Sains Malaysia, Pulau Pinang, Penang, Malaysia Aileen Dualan, MD, MS, Asia Pacific Medical Affairs Lead, MSD International GmBH, Singapore Aileen Neilson, MSc, Health Economist, Health Economics Research Unit, Aberdeen University, Aberdeen, UK Aisling Murphy, MPharm, MSc, Health Economist, Novartis Ireland Ltd., Dublin, Ireland Ajibade Ashaye, MD, MPH, MS, Research Scientist, Evidera Inc., Waltham, MA, Akshaya Bhagavathula, PharmD, Assistant Professor of Clinical Pharmacy, University of Gondar, Gondar, Amhara, Ethiopia Alanna Chamberlain, PhD, Assistant Professor of Epidemiology, Mayo Clinic, Rochester, MN, Alex Upton, MSc, Health Economist, Bayer, UK Alex Exuzides, PhD, Senior Research Leader, Evidera, San Francisco, CA, Alexandr Kostyuk, MD, PhD, Head of Center for Clinical Excellence, Republican Center for Healthcare Development, Astana, Kazakhstan Alexia Marrel, Associate Director, Mapi Group, Lyon, France Alima Almadiyeva, MPH, Executive Director, Kazakh Agency for Health Technology Assessment, Astana, Kazakhstan Amanda Dawson, PhD, Director of Research, Select Medical, Mechanicsburg, PA, Amer Khan, PhD, Senior Lecturer, Universiti Sains Malaysia, Penang, Malaysia Ami Vyas, PhD, Assistant Professor, The University of Rhode Island, Kingston, RI, Amie Scott, MPH, Executive Leader/Consumer Research, SEAS Capital Partners, New York, NY, Amir Viyanchi, PhD, Budget Analyst, Hamedand University of Medical Sciences, Hamadan, Iran Ammar Awadh, PhD, Assistant Professor, International Islamic University Malaysia (IIUM), Kuantan, Pahang, Malaysia Ana Popielnicki, BA, Senior Director, COA Consulting, TransPerfect, Boston, MA, Anan Udombhornprabha, BPharm, MPharm, MSc, MBA, PhD, Researcher, Instructor and Curriculum Faculty Member, Eastern Asia University School of Pharmacy, Thunyaburi, Pathumthani, Thailand Anantha Nagappa, PhD, Director, SCS College of Pharmacy, Harapanahalli, Karnataka, India Andrea Marcellusi, PhD, Ceis University of Rome Tor Vergata, Roma, Italy

6 Andrea Lorden, PhD, MPH, Assistant Professor, University of Oklahoma Health Sciences Center, Oklahoma City, OK, Andrew Palsgrove, BA, PRO Manager II, Covance Market Access, Inc., Gaithersburg, MD, Andrew Manton, BEc, MEpi, Owner/Director, HEARS (Health Economics Consultancy), Melbourne, VIC, Australia Andrew Worsfold, BSc (Hons), Director, Independent, Cambridge, UK Andrew Metry, BSc, Pharmacoeconomist, Egyptian Drug Authority, Cairo, Egypt Andrew Lloyd, DPhil, Director, Acaster Lloyd Consulting Ltd, London, UK Andrew Peterson, PharmD, PhD, Dean, University of the Sciences in Philadelphia, Philadelphia, PA, Andrew Klink, PhD, MPH, Manager, HEOR, Cardinal Health, Philadelphia, PA, Angela Rylands, PhD, Consultant In Patient Centered Outcomes, ph Associates an OPEN Heath Company, London, UK Anibal Garcia-Sempere, MSc, Real World Evidence Researcher, CSISP-FISABIO Foundation For Biomedical Research Of Valencia, Valencia, Spain Aniket Kawatkar, PhD, MS, Research Scientist, Kaiser Permanente Southern California, Pasadena, CA, Anil Vaidya, MPH, PhD, Research Associate, University of Alberta, Edmonton, Alberta, Canada Anita Csordás, MSc, Health Economic Analyst, National Institute of Pharmacy and Nutrition, Budapest, Budapest, Hungary Anita Chawla, PhD, Managing Principal, Analysis Group, Menlo Park, CA, Ankur Pandya, PhD, Assistant Professor of Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA, Anna Seiffert, MSc, Senior Analyst, Gesundheitsforen Leipzig GmbH, Leipzig, Saxony, Germany Anna Forsythe, PharmD, MSc, MBA, Managing partner, Purple Squirrel Economics, New York, NY, Anne Postulka, MD, Senior Director, Medical & Economic Value, Europe, Cepheid Europe, Maurens-Scopont, France Anthony Budden, BBHSc, Health Economist, CADTH, Ottawa, ON, Canada Antonio Escobar, MD, PhD, Researcher, Hospital Universitario Basurto, Bilbao, España Antonio, Garcia-Ruiz, PhD, MD, MS, Chair Health Economics & Rational Drug Use, University of Malaga, Malaga, Spain Anup Luitel, MPharm, Lecturer, Chitwan Medical College, Bharatpur, Chitwan, Nepal Arely Lemus, MSc, Access Director, Celgene Mexico, Mexico City, Mexico Arjun Subedi, MPH, MA, Program Advisor, PSI Nepal, Kathmandu, Nepal Arto Ohinmaa, PhD, Professor, School of Public Health, University of Alberta, Edmonton, Alberta, Canada Ashish Joshi, PhD, Senior Director, Value Evidence Leader, GlaxoSmithKline, Collegeville, PA, Asmaa Abourawash, Member of Pharmacoeconomic Unit -Ministry Of Health, Central Administration of Pharmaceutical Affairs, Cairo, Egypt Asnakew Achaw Ayele, BPharm, Lecturer, University of Gondar, Gondar, Amhara, Ethiopia Asrul Akmal, Shafie, PhD, Associate Professor, Universiti Sains Malaysia, USM, Penang, Malaysia Ateequr Rahman, PhD, Associate Professor, Rosalind Franklin University, North Chicago, IL, Balint Molics, PhD, Senior Lecturer, University of Pecs, Pecs, Baranya, Hungary Barbara Zarowitz, PharmD, Independent Consultant and Adjunct Faculty, Barbara J Zarowitz LLC, Orchard Lake, MI,

7 Barbara Ramos, PhD, Associate Medical Director, Astellas Pharma Canada, Markham, ON, Canada Begashaw Melaku Gebresillassie, BPharm, Lecturer, University of Gondar, Gondar, Amhara, Ethiopia Belinda Mohr, PhD, Health Economist, W. L. Gore & Associates, Inc., Phoenix, AZ, Benedicte Les, MSc, Director, Outcomes Research, Xintera Ltd, Cambridge, UK Benjamin Gutierrez, PhD, Head, VEO Scientific Excellence, GlaxoSmithKline, Collegeville, PA, Bhavana Bhat, MPharm, Research Scholar, Manipal College of Pharmaceutical Sciences, Manipal, Karnataka, India Bihari Gupta, PhD, Assistant Professor, L.N. Mithila University, Darbhanga, Bihar, India Bik Wai Tai, PharmD, Assistant Professor, Caritas Institute of Higher Education, Hong Kong, China Binai Sankar, MPharm, Assistant Professor, Acharya & BM Reddy College of Pharmacy, Bangalore, Karnataka, India Boyang Bian, PhD, Principal Health Economics Analyst, Medtronic, Minneapolis, MN, Boyka Stoykova, MD, MSc, Senior Director GHEOR, Daiichi Sankyo, Gerrards Cross, UK Bradley Stolshek, PharmD, Director, Global Health Economics, Amgen, Thousand Oaks, CA, Brigitte Klinkenbijl, MSc, MBA, Director International Access, Dexcom, Edinburgh, Scotland Bryan Bennett, PhD, Director, Patient-Centered Outcomes, Adelphi Values, Bollington, Cheshire, UK Busuyi Olotu, PhD, Assistant Professor, West Coast University School of Pharmacy, Los Angeles, CA, Carl Abelardo Antonio, MD, MPH, Assistant Professor, College of Public Health, University of the Philippines Manila, Philippines Carla Vossen, PhD, Senior Consultant, BresMed, Utrecht, Utrecht, The Netherlands Carlos Polanco, PhD, HEOR Lead Spain & Portugal, Bristol-Myers Squibb, Madrid, Spain Carlos Martin Saborido, PhD, Director, HTA unit Universidad Francisco de Vitoria, Madrid, España Carole Jones, BSc, MBA, Director, Market Access, VCLS, London, Middlesex, UK Carole Chrvala, PhD, President, Health Matters, Inc., Pittsboro, NC, Caroline McKay, PhD, Center for Observational & Real World Evidence, Merck & Co., Inc., Caroline Watts, PhD, Research Fellow, The University of Sydney, Sydney, NSW, Australia Catarina Silva, BSc, Health Economics Manager, Eurotrials, Scientific Consultants, Lisbon, Portugal Catherine Bottomley, MPharm, PhD, Associate Director, ph Associates (an Open Health company), Marlow, UK César Alberto Cruz Santiago, PhD, Advisor, Pemex, Mexico, Miguel Hidalgo, México Chao Song, MPH, Health Economist, Intuitive Surgical, Sunnyvale, CA, Charles Daniels, BPharm, PhD, Clinical Professor & Associate Dean of Pharmacy, University of California San Diego, La Jolla, CA, Charles Carter, BS, PharmD, MBA, Associate Professor, CPHS, Campbell University, Buies Creek, NC, Che Zin, PhD, Assistant Professor, International Islamic University Malaysia, Kuantan, Pahang Darul Makmur, Malaysia Cheng-Shyong Chang, MD, Attending Physician, Changhua Christian Hospital, Changhua, Taiwan Cheryl Coon, PhD, Principal, Outcometrix, Tucson, AZ,

8 Chiahung Chou, PhD, Associate Professor, Auburn University Harrison School of Pharmacy, Auburn, Alberta, Chi-Chang Chen, PhD, Director, QuintilesIMS, Plymouth Meeting, PA, Chin Fen Neoh, BPharm(Hons), MClinPharm, PhD, Senior Lecturer, Universiti Teknologi MARA, Puncak Alam, Selangor, Malaysia Christel Naujoks, MSc, MPH, MHlthEcon, MBA, MAS, HE, Executive Director, HEOR, Novartis Pharma AG, Basel, Switzerland Christian Gericke, MD, PhD, MPH, MSc, Professor, University of Queensland, Brisbane, Queensland, Australia Christoph Goergen, MSc, Healthcare Data Analyst EMEA, Abbott Vascular, Brussels, Belgium Christoph Gerlinger, Senior Director, Bayer AG, Berlin, Germany Christopher Graham, MS, Senior Director, RTI Health Solutions, Research Triangle Park, NC, Chunhuan Lao, PhD, Postdoctoral Research Fellow, University of Waikato, Hamilton, New Zealand Claire Burbridge, MSc, Senior Director, Clinical Outcomes Solutions, Folkestone, Kent, UK Claire Grant, MSc, Head of HK & Ireland HEOR, Sanofi, Guildford, Surrey, UK Claire Rothery, PhD, Senior Research Fellow in Health Economics, University of York, York, UK Clara Weil, MSPH, Epidemiologist, Maccabi Healthcare Services, Tel Aviv, Israel Clark Paramore, MSPH, Head of Value Demonstration, Bluebird Bio, Cambridge, MA, Claudia Pitotti, Health Economics Manager, Novartis Farma Italy, Milan, Italy Clemence Arvin-Berod, PharmD, Global HEOR & Market Access Manager, Xcenda Switzerland, Geneva, Switzerland Colleen McHorney, PhD, Senior Research Leader, Evidera, Bethesda, MD, Cristina Antón Rodríguez, Researcher, Francisco de Victoria University HTA Unit, Madrid, Spain Dale Hanna, BS, Product Manager, Lash Group, Charlotte, NC, Dan Wasserman, BA, Business Operations Manager, KJT Group, Honeoye Falls, NY, Dan Tucker, BMedSc, MBBS, FRACGP FRSPH, Senior Consultant, Hobart, Tasmania, Australia Dan Daneasa, MSc, Pharm, Independent Researcher, Free University of Brussels, Brussels, Belgium Dana Drzayich Jankus, MS, Research Consultant, Comprehensive Health Insights, Louisville, KY, Daniel Touchette, PharmD, MA, Associate Professor of Pharmacy, University of Illinois at Chicago, Chicago, IL, Danielle Norman, BSc, Associate Consultant - Health Economics, MAP BioPharma, Cambridge, Cambridgeshire, UK Danielle Zammir, PhD, Healthcare Exonomist, Basel, Switzerland Danini Contreras, BSc, Director, Drug Inspectorate Unit, Ministry of Health, Belmopan, Cayo, Belize David Pau, MSc, Statistician, Roche, Boulogne-Billancourt, France David Walker, PhD, Director, HEOR, Astellas, Northbrook, IL, Debanjali Mitra, MBA, MA, Director, Outcomes and Evidence, Pfizer, Inc., New York, NY, Debarshi Kar Mahapatra, Assistant Professor, Dadasaheb Balpande College Of Pharmacy, Nagpur, Maharashtra, India Deborah Taira, ScD, Professor, DKICP College of Pharmacy, University of Hawaii, Honolulu, HI, Dena Jaffe, PhD, Manager, Kantar Health, Tel Aviv, Israel Dennis Häckl, PhD, Managing Director, WIG2 GmbH, Leipzig, Germany

9 Denny John, MBA, MPH, Evidence Synthesis Specialist, Campbell Collaboration, New Delhi, India Devesh Kumar Joshi, PharmD, Assistant Professor, SGRRITS, Dehradun, Uttarakhand, India Diane Whalley, PhD, Senior Director, Patient-Centered Outcomes Assessment, RTI Health Solutions, Manchester, UK Diego Rosselli, MD, EdM, MSc, Professor of Health Economics, Pontificia Universidad Javeriana, Bogota, Colombia Dilip Makhija, MS, Manager, Global HEOR, Baxter Healthcare, Deerfield, IL, Dixon Thomas, MPharm, PhD, Assistant Professor, Gulf Medical University, Ajman, United Arab Emirates Dominic Jones-Phillips, PhD, Market Access Consultant, Valid Insight, London, UK Don Bushnell, MA, Director, HRA, Inc., Seattle, WA, Donald Stull, PhD, Head, Data Analytics and Design Strategy, RTI Health Solutions, Research Triangle Park, NC, Donatus (Don) Ekwueme, PhD, MS, Senior Health Economist, U.S. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, Dong Dai, PhD, Associate Director of HEOR, Novartis, East Hanover, NJ, Donna Chiefari, PharmD, Clifton Park, NY, Dora Endrei, PhD, MSc, MD, Deputy General Director, University of Pécs, Pécs, Baranya, Hungary Doreen McBride, PhD, Head, HTA Health Economics Strategy and Research, RTI Health Solutions, Manchester, UK Edit Remak, PhD, Senior Research Scientist, Evidera Inc., Budapest, Hungary Eduardo Sabate, MD, MBA, MPH, Senior Director, Oncology Pipeline GMAP, Merck Serono SA, Aubonne, VD, Switzerland Edward Drea, PharmD, Director, Sanofi-Genzyme, Cambridge, MA, Edward Lee, PharmD, Director & Head of HEOR, UCB, Smyrna, GA, Efstathios Michalopoulos, MPH, Scientist, Pharmerit, Bethesda, MD, Eileen Ming, MPH, ScD, Principal, Epi Excellence LLC, Garnet Valley, PA, Eileen Baranowski, PharmD, MS, Field HEOR Director, Sanofi, Wexford, PA, Elena Pyadushkina, PharmD, Researcher, The Russian Presidential Academy of National Economy and Public Administration, Moscow, Russia Elena Chitan, PhD, Assistant Professor, State University of Medicine and Pharmacy "Nicolae Testemitanu", Chisinau, Moldova Elise Chia-Hui Tan, PhD, Assistant Research Fellow, National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei City, Taiwan Eliza Wong, PhD, Associate Professor, The Chinese University of Hong Kong, Hong Kong Elizabeth Mearns, PharmD, Researcher, IBM Watson Health, Philadelphia, PA, Elizabeth La, PhD, Associate Director, Health Economics, RTI Health Solutions, Research Triangle Park, NC, Emmanuelle Préaud, PharmD, MSc, Market Access Senior Manager, Merck, Lyon, France Engels Obi, PhD, BPharm, Associate Director, HE&OR, Novartis Pharmaceuticals, East Hanover, NJ, Ergun Oksuz, Professor, Baskent University, Ankara, Turkey Eric Nsiah-Boateng, MPH, MSc, University of Ghana School of Public Health, Accra, Ghana Eric Wittbrodt, PharmD, MPH, Director, HEOR, AstraZeneca, Wilmington, DE, Erin Gavin, PharmD, BCPS, Director of Pharmaceutical Research, Procured Health, Chicago, IL,

10 Esraa Mady, BPharm, Pricing specialist, Central Administration of Pharmaceutical Affairs (CAPA), Cairo, Egypt Evo Alemao, MS, RPh, Group Director, BMS, Princeton, NJ, Eyob Alemayehu Gebreyohannes, MSc, Lecturer, University of Gondar, Gondar, Amhara, Ethiopia Fahad Saleem, PhD, Associate Professor, University of Balochistan, Quetta, Balochistan, Pakistan Fatou Ceesay, MPH, Program Associate, Patient-Centered Outcomes Research Institute, Washington, DC, Ferg Mills, MSc, Director, Innomar Consulting, Oakville, ON, Canada Feroza Perveen, MPharm, Senior Pharmacist, Aga Khan University Hospital, Karachi, Sindh, Pakistan Florian Eichmann, PhD, Principal RWE, Late Stage, Inventiv Health, Munich, Germany Foluso Agboola, MBBS, MPH, Research Scientist, Institute for Clinical and Economic Review, Boston, MA, Francis Staskon, PhD, Senior Analyst, Walgreen Co, Deerfield, IL, Frank Ernst, PharmD, MS, Marietta, GA, Fredrick Orkin, MD, MBA, SM, Retired, Former Professor Of Anesthesiology & Health Evaluation Sciences, Formerly, Pennsylvania State University College Of Medicine, Hershey, PA, Gayane Khachatryan, MD, Safety Monitor, FMD KL Europe, Yerevan, Armenia Gene Reeder, PhD, Director, Kennedy Pharmacy Innovation Center, University of South Carolina, Columbia, SC, Genevieve Bonnelye, MSc, Managing Director, Kantar Health, Paris, France Ghislaine van Mastrigt, PhD, Researcher, Maastricht Research & More, Maastricht, The Netherlands Giancarlo Carmosino, MD, MBA, Medical Affairs Oncology, Pfizer, Rome, Italy Giles Monnickendam, MSc, Senior Consultant, PRMA Consulting, Fleet, Hampshire, UK Giuditta Callea, PhD, Research Fellow, Centre for Research on Health and Social Care Management (Cergas), Bocconi University, Milan, Italy Godofreda Dalmacion, MD, MSc, MHPEd, Professor, University of the Philippines Manila, Ermita, Manila, Philippines Gottfried Endel, Head of HTA Working Group, Head Association Of The Austrian Social Insurance Companies, Vienna, Austria Gouri Shankar Bhattacharyya, MD, PhD, MRCP, Medical Oncologist, Salt Lake Medical Centre, Kokata, West Bengal, India Grace Wang, MS, Senior Scientist, Janssen Pharmaceuticals/ Data Science, Spring House, PA, Grace Antony, MSc, PhD, Senior Scientist, MSD, London, UK Graciela Luraschi, Academic, Isalud University, CABA, Argentina Greeshma Musunuru, DPharm, Assistant Professor, Chalapathi Institute of Pharmaceutical Sciences, Guntur, Andhra Pradesh, India Grégoire Mercier, MD, PhD, Head of The Economic Evaluation Unit, CHU Montpellier, Montpellier, France Guenka Petrova, DSci, Professor, Medical University of Sofia, Sofia, Bulgaria Gunhild Hagen, MPhil, Market Access Manager, Pfizer, Oslo, Norway Gunjan Shah, MD, MS, Assistant Attending, Memorial Sloan Kettering Cancer Center, New York, NY, Günther Zauner, MSc, Head of Healthcare and Cost Modelling, DWH GmbH, Vienna, Austria Guy Edwards, PhD, Associate Consultant, QuintilesIMS, Cambridge, UK

11 Haim Erder, PhD, Principal, M. Haim Erder Health Economics Inc, Livingston, NJ, Haitham Tuffaha, BPharm, MSc, MBA, PhD, Senior Research Fellow, Griffith University, Brisbane, Queensland, Australia Hankil Lee, PhD, Yonsei University, Incheon, South Korea Harblas Ahir, MSc, MPharm, Senior HTA Manager, MSD UK, Hoddesdon, Herts, UK Haruhisa Fukuda, MPH, PhD, Associate Professor, Kyushu University, Fukuoka, Fukuoka, Japan Hayley de Freitas, MSc, Research Consultant, Mapi, Patient-Centered Sciences, White City, London, UK Heather Stegenga, MSc, BHSc, Senior Analyst, NICE, London, UK Henok Tegegn, MSc, Assistant Professor, University of Gondar, Gondar, Amhara, Ethiopia Hiltrud Liedgens, Head HEOR, Gruenenthal GmbH, Aachen, Germany Himanshu Patel, MPharm, PhD, Assistant Professor & Clinical Pharmacist, JSS College of Pharmacy, JSS University, Mysore, India, Mysore, Karnataka, India Hiroyuki Okumura, PhD, HEOR, Astellas Pharma Inc., Medical Affairs, Tokyo, Japan Hossam Samouly, Head Of Pharmacy, Police Hospital, Cairo, Egypt Hsien-Chang Lin, PhD, Assistant Professor, Indiana University School of Public Health, Bloomington, IN, Hugh Kawabata, MA, Retired, Bristol-Myers Squibb, Hopewell, NJ, Humberto Maciel, Market Access Head, CSL Behring, Mexico City, Mexico Ian Johnson, BSc, Senior Director, McCann Health, Macclesfield, Cheshire, UK I-Chan Huang, PhD, Associate Professor, St. Jude Children's Research Hospital, Memphis, TN, Iengeniia Melnyk, MA, Head of the Department of European Integration and International Relations, State Expert Center of the Ministry of Health of Ukraine, Kyiv, Ukraine Ievgeniia Rubtsova, MA, Expert, State Expert Centre of the Ministry of Health of Ukraine, Kiev, Ukraine Ilaria Palla, MBA, Research Assistant, Scuola Superiore Sant'Anna, Pisa, Italy Ilse Truter, Dcom, BPharm, MSc, PhD, Professor in Pharmacy & Leader of Drug Utilization Research Unit (DURU), Nelson Mandela Metropolitan University, Port Elizabeth, Eastern Cape, South Africa Imre Boncz, MD, MSc, PhD, Habil, Professor & Director, University of Pécs, Pécs, Hungary Inmaculada Hernandez, PharmD, PhD, Assistant Professor, University Of Pittsburgh, Pittsburgh, PA, Irina Tikhonova, PhD, Research Associate, PenTAG, ESMI, Exeter Medical School, Exeter, Devon, UK Irina (Iryna), Kozhanova (Kazhanava), PhD, Assistant Professor, Belarusian State Medical University, Minsk, Belarus Iris Contreras, Coordinador Clinico de Educación e Investigación en Salud, Hospital General de Zona 1-A del Instituto Mexicano del Seguro Social, Mexico, Ciudad de Mexico, Mexico Ishveen Chopra, PhD, Senior Research Analyst, Pharmerit International, Bethesda, MD, Istvan Agoston, BSc, JD, PhD, Lecturer, University of Pécs, Pécs, Hungary Izhar Hussain, PhD, Director Executive Education, Institute of Business Administration, Karachi, Pakistan Jade Marshall, MSc, Associate Director Health Economics, MAP BioPharma Limited, Papworth, Cambridge, UK James Piercy, MSc, Chief Scientist, Adelphi Real World, Bollington, Cheshire, UK James Shaw, PhD, Director, WWHEOR, Bristol-Myers Squibb, Lawrenceville, NJ, James Wilson, PhD, Associate Professor, University Of Texas at Austin, Austin, TX,

12 Jamie Partridge, PhD, Director, Global Scientific Affairs, Abbott Nutrition, Columbus, OH, Jan McKendrick, MSc, Senior Director, PRMA Consulting Ltd, Fleet, Hampshire, UK Ján Bielik, MD, PhD, University Teacher, Faculty of Healthcare, Trencin University, Trencin, Slovak Republic Janki Chauhan, PharmD, Nairobi, Kenya Jasmanda Wu, PhD, MS, MBA, Senior Director, Sanofi, Bridgewater, NJ, Jay Margolis, PharmD, Senior Research Scientist, IBM Watson Health, Bala Cynwyd, PA, Jean Lachaine, PhD, Professor, University of Montreal, Montreal, Canada Jean-Gabriel Le Moine, MSc, Senior Statistician, RTI Health Solutions, Manchester, Royaume-Uni Jeffrey Miller, MS, Director, Economic Modeling, Truven Health Analytics, an IBM Company, Cambridge, MA, Jennifer Drahos, PhD, MPH, Global Outcomes Research Senior Manager, Takeda Pharmaceuticals, Cambridge, MA, Jennifer Wing, Consultant, Crawford Research, Paris, France Jiat Ling Poon, PhD, Research Scientist, Evidera, Bethesda, MD, Jing Hao, PhD, MD, MS, MPH, Assistant Professor, Geisinger Health System, Danville, PA, Jisha Lucca, PhD, JSS University/JSS College of Pharmacy, Mysore, Karnataka, India Joanna Entwistle, PhD, Director Market Access, GfK, London, UK Joanna Le niowska, PhD, Assistant Professor, Kozminski University, Warsaw, Poland Joanna Thorn, PhD, Senior Research Associate in Health Economics, University of Bristol, Bristol, UK John Cook, PhD, Vice President, Economic Modeling, Complete HEOR Solutions, North Wales, PA, Jone Gerdvilaite, Reimbursment & HTA, Med-El, Innsbruck, Austria JoonSu Kim, MPharm, Market Access Director, Abbvie Korea, Seoul, Seoul, South Korea Jose Manuel Rodriguez Barrios, PhD, Pricing, Economics & Market Access Strategy Director EU, Daiichi Sankyo EU, Munich, Bavaria, Germany Joseph Feliciano, PharmD, Manager, HEOR, Seattle Genetics, Bothell, WA, Joseph Menzin, PhD, Founder & Chief Executive Officer, BHE, Newton, MA, Joyce Addo-Atuah, PhD, Associate Professor, Touro College of Pharmacy, New York, NY, Juan Carlos Alva Pinto, MD, Doctor, Hospital Nacional Edgardo Rebagliatti Martins, Lima, Peru Judith O'Brien, RN, BSPA, Independent Consultant, Lincoln, MA, Julian Prescod, MPhil, Manager (Acting), Research and Development Department, National Insurance Board of Trinidad and Tobago, Port of Spain, Trinidad and Tobago Jun Wu, PhD, Associate Professor, Presbyterian College, Clinton, SC, Justin Carrico, BS, Research Health Economist, RTI Health Solutions, Durham, NC, Justin Kurian, PharmD, Lecturer & Clinical Pharmacist, JSS College of Pharmacy, JSS University, Mysore, Mysore, Karnataka, India K.V. Ramanath, MPharm, MBA(HRD), Associate Professor & QIP Research Scholar, SAC College of Pharmacy, BG Nagar, Karnataka, India Kalman Emry Wijaya, PharmD, MBA, Global Market Access and Policy Senior Manager, Abbott Products Operations AG, Allschwil, Basel Land, Switzerland Kalyani Sonawane, PhD, Assistant Professor, University of Florida, Gainesville, FL, Karin Sennfalt, PhD, Patient Access Lead, Nordics & Baltics, Swedish Orphan Biovitrum AB, Stockholm, Sweden Karunrat Tewthanom, PhD, Assistance Professor, Silpakorn University, Meaung, NakhonPathom, Thailand Katharina Buesch, MSc, Head of HEOR & HTA, AbbVie, Stockholm, Sweden

13 Katherine Etter, PhD, Manager, Healthcare Analytics, HEMA, Johnson and Johnson, Raynham, MA, Katrin Radl, BSc, MIHMEP, Market Access Manager, Takeda, Zurich, Switzerland Keary Zhou, DPharm, Lecturer, The Chinese University of Hong Kong, Shatin, Hong Kong Kednapa Thavorn, PhD, Scientist, Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, Canada Keith Carnes, PhD, Research Assistant Professor, University of North Carolina at Charlotte, Charlotte, NC, Kelly Fleetwood, MSc, Principal Statistician, Quantics Biostatistics, Edinburgh, UK Kenji Adachi, PhD, Associate Director, Gilead Sciences, Tokyo, Japan Kibum Kim, PhD, Senior Research Analyst, University of Utah, Salt Lake City, UT, Kirandeep Kaur, MD, Associate Professor, Dayanand Medical College and Hospital, Ludhiana, India Kirstin Heinrich, MPH, Manager, Outcomes & Evidence, Pfizer, Collegeville, PA, Klas Bergenheim, PhD, Global Group Director Health Economics CVMD, AstraZeneca, Molndal, Sweden Krzysztof Lach, MPH, Pricing & Market Access Associate Manager, Creativ-Ceutical, Krakow, Malpolskie, Poland Lang Hui-Chu, PhD, Professor, National Yang-Ming University, Taipei, Taiwan Lars Nicklasson, PhD, Senior Director Global Pricing & Market Access, Celgene International, Boudry, Switzerland LaStella Miles, MS, Senior Research Health Economist, RTI Health Solutions, Research Triangle Park, NC, Laura Elisabeth Smith, MSc, Associate Research Consultant, Pharmerit International, York, Yorkshire, UK Linda Gore Martin, PharmD, MBA, BCPS, Professor Emeritus, University of Wyoming School of Pharmacy, Laramie, WY, Lindsey Falk, MPH, Health Economist, Health Quality Ontario, Toronto, ON, Canada Ling Zhang, MD, MPH, MSc, Manager & Data Scientist, Janssen, Johnson and Johnson, Raritan, NJ, USE Lionel Perrier, PhD, Health Economist, Cancer Centre Léon Bérard, Lyon, France Lita Araujo, PhD, Faculty, MCPHS University, Boston, MA, LoAn Ho, PharmD, Associate Director, Xcenda, Tampa, FL, Lotte Steuten, PhD, Associate Member & Professor, Fred Hutch Cancer Research Center, University of Washington, Seattle, WA, Louise Hansen, PhD, Assistant Professor, Aalborg University, Aalborg, Denmark Louise Anderson, PhD, Health Economist, Technomics Research LLC, Minneapolis, MN, Lucy Eddowes, Mchem, DPhil, Head of the Multidisciplinary Division, Costello Medical Consulting, Cambridge, Cambridgeshire, UK Lucy Michael, MSc, PharmD, Managing Director, Applied Health Value Solutions, Tacoma, WA, Lutz Vollmer, MSc, Health Economist, MArS - Market Access & Pricing Strategy GmbH, Weil am Rhein, Germany, Deutschland Lyna Irawati, MPharm, Universiti Sains Malaysia, Penang, Malaysia Lynda Doward, MRes, European Head, Patient Centered Outcomes Assessment, RTI-Health Solutions, Manchester, UK Machaon Bonafede, MPH, PhD, Senior Director, Truven Health Analytics, an IBM Company, Cambridge, MA,

14 Maelys Touya, PharmD, Associate Director, Lundbeck, Deerfield, IL, Mahendra Rai, MPharm, Delivery Head, HEOR & Market Access, Tata Consultancy Services, Mumbai, Maharashtra, India Mahmood Ahmad, PhD, Dean, Faculty of Pharmacy & Alternative Medicine, The Islamia University of Bahawalpur, Bahawalpur, Punjab, Pakistan Maite Artés, MSc, Managing Director, Adelphi Spain, Barcelona, Barcelona, Spain Mamo Girma Tefera, MSc, Lecturer and Health Economics Focal Person, Addis Ababa Science and Technology University, Liverpool School of Tropical Medicine, Addis Ababa, Ethiopia Manal El-Hamamsy, PhD, Professor & Head Of Pharmacy Practice Department, Faculty Of Pharmacy, Heliopolis University, Cairo, Egypt Manthan Janodia, MPharm, PhD, Associate Professor, Manipal College of Pharmaceutical Scienes, Manipal University, Manipal, Karnataka, India Marcel Braun, BSc, MBA, Senior Manager Market Development, Inspire Medical Systems, Inc., Maple Grove, MN, Marco Boeri, PhD, Senior Economist, RTI-HS HPA Group, Belfast, Antrim, UK Maria Beatriz Coutinho, Bachelor, HTA Senior Manager, MSD Brazil, São Paulo, Brazil Marie Barnard, PhD, Assistant Professor of Pharmacy Administration, University of Mississippi, University, MS, Marie-Josee Martel, PhD, Senior Director, Global HEOR & Market Access, Xcenda (UK) Ltd, London, UK MariKannan Maharajan, BPharm, MPharm, PhD, University Lecturer, International Medical University Malaysia, Kuala Lumpur, Malaysia Mark Belger, BSc, Principal Research Scientist, Eli Lilly, Windlesham, Surrey, UK Mark Schulz, PhD, Director Market Access, Novartis, Sydney, NSW, Australia Mary Gawlicki, MBA, Founder, Gawlicki Family Foundation, Hartford, CT, Mary Lynn Davis-Ajami, PhD, MBA, MS, FNP, Assistant Professor, Virginia Commonwealth University, Richmond, VA, Mason Russell, Vice President, Strategic Consulting, IBM Watson Health, Cambridge, MA, Matthew Taylor, PhD, Director, York Health Economics Consortium, York, North Yorkshire, UK Matthias Bischof, MPharm, MSc, PhD, Global Value Strategy & Access, Shire, Zug, Switzerland Meghan Gavaghan, MPH, Principal Consultant, GfK, Waltham, MA, Mei-Chuan Hung, PhD, Research Fellow, U.S. Centers for Disease Control, Atlanta, GA, Melanie Lucero, MPH, Director, Health Economics & Outcomes Research, Medtronic, Mansfield, MA, Melodi Kosaner Kliess, MRes, Scientific Publications Specialist, MED-EL, Innsbruck, Austria Michael Minshall, BS, MPH, Senior Director, HEOR, CTI Clinical Trial and Consulting, Covington, KY, Michael Carter, MBA, Consultant, Carter-Lis Associates Ltd, London, UK Michael Ganz, MS, PhD, Senior Research Scientist, Evidera, Waltham, MA, Michael Forstner, MS, PhD, FRSPH, Managing Director, Mesama Consulting, Baerschwil, Switzerland Michael Kuehn, PharmD, MBA, Vice President, GfK Market Access, New York, NY, Michael Adena, PhD, Director, Datalytics Pty Ltd, Canberra, ACT, Australia Michael Willis, PhD, Research Director, The Swedish Institute for Health Economics, Lund, Sweden Michele Cole, PharmD, MS, Managed Markets/HEOR, Actelion Pharmaceuticals, South San Francisco, CA, Miguel A. Ruiz, PhD, Professor, Universidad Autónoma de Madrid, Madrid, Spain

15 Miguel Ángel Ruiz Díaz, PhD, Associate Professor, Universidad Autónoma de Madrid, Madrid, Spain Mike Storm, MSc, Senior Manager, Global Pricing and Reimbursement, Alexion Pharmaceuticals, Washington, DC, Milena Anatchkova, PhD, Research Scientist, Evidera, Waltham, MS, Minghui Li, PhD, Assistant Professor, University of Tennessee Health Science Center, Memphis, TN, Mohamed Elnaem, PharmD, Lecturer, Faculty of Pharmacy, International Islamic University Malaysia, Kuantan, Pahang, Malaysia Mohammed Assen Seid, BPharm, Assisstant Lecturer, University of Gondar, Gondar, Amhara, Ethiopia Molly Purser, PhD, Associate Director, Health Economics, RTI-Health Solutions, Research Triangle Park, NC, Monica Cintra, MD, PhD, Clinical Research Unit Coordinator, UPC HC FMRP USP, Ribeirão Preto, São Paulo, Brazil Monika Szkultecka-Debek, Region Europe Access Evidence and RWE Leader, ROCHE Mousam Parekh, MS, Manager, Allergan, Bridgewater, NJ, Muhammad Akhtar, PhD, Assistant Professor, The Islamia University of Bahawalpur, Bahawalpur, Punjab, Pakistan Mujde Erten Nadine Hillock, MPH, BPharm, Public Health Pharmacist, University of Adelaide, Adelaide, South Australia, Australia Nanxin (Nick) Li, PhD, MBA, HEOR Lead, Bioverativ, Waltham, MA, Nati Calvente, PhD, Policy, MSD, Madrid, Spain Nayanabhirama Udupa, MPharm, PhD, Research Director, Manipal University, Manipal, Karnataka, India Necdet Gunsoy, PhD, Manager, Analytics and Innovation, GlaxoSmithKline, London, UK Neeraj Iyer, PhD, Manager, HEOR, Novo Nordisk Inc., Bordentown, NJ, Nicolas Touchot, PhD, MBA, Director, Therapeutic Challenges Analysis, London, UK Nikki McCaffrey, PhD, Senior Research Fellow (Health Economics - Cancer), Deakin Health Economics, Deakin University, Melbourne, Victoria, Australia Nikolaos Kotsopoulos, PhD, Director, Global Market Access Solutions, Geneva, Switzerland Ning Zhu, MPH, Senior Analyst, Walgreen Co., Deerfield, IL, Nipun Atreja, PhD, Manager, Alkermes, Waltham, MA, Nirmal Gurbani, PhD, PGDHRM, LLB, Professor (Pharmaceutical Management), IIHMR University, Jaipur, Rajasthan, India Nishkarsh Likhar, MPharm, Associate Consultant, MHS, Mumbai, India Noman ul Haq, PhD, Assistant Professor, University of Balochistan, Quetta, Balochistan, Pakistan Norbert Banik, PhD, MD, Managing Director, Winicker Norimed Medical Research GmbH, Munich, Bavaria, Germany Nuno Silverio, PharmD, RPh, MBA, Director of Market Access & Governmental Affairs, Merck SA, Lisbon, Portugal Nurhafiza Md Hamzah, Senior Assistant Director, Pharmaceutical Services Division, Petaling Jaya, Selangor, Malaysia Nyashadzaishe, Mafirakureva, PhD, Senior Research Associate, University of Bristol, Bristol, UK Oktay Ozdemir, General Director, Yorum Consulting Company, Istanbul, Turkey Olga Sánchez-Soliño, MD, Global Neuroscience Therapeutic Area Head - Global Medical Affairs, AbbVie, Madrid, Spain

16 Olivia Phung, PharmD, Assistant Professor, California Northstate University College of Pharmacy, Elk Grove, CA, Oluwadolapo Lawal, MPH, Research Associate, Analgesic Solutions, Natick, MA, Omar Thanoon Dawood, PhD, Researcher, Ministry of Science and Technology, Baghdad, Iraq Omid Beiki, MD, PhD, Researcher, Karolinska Institutet, Stockholm, Sweden Osamu, Takahashi, MD, MPH, PhD, Professor, St. Luke's International University, Tokyo, Japan Palanisamy Sivanandy, MPharm, PhD, Lecturer, International Medical University, Kuala Lumpur, Malaysia Paolo Angelo Cortesi, PhD, Research Fellow, Research Centre on Public Health (CESP) - University of Milano Bicocca, Monza, Italy Parul Agarwal, PhD, Health Economics Researcher, Mount Sinai Health Systems, New York, NY, Pascale Brasseur, MSc, HEOR Director, Medtronic plc, Tolochenaz, Vaud, Switzerland Patricia Harrington, PhD, Head of Assessment, HTA, HIQA, Dublin, Ireland Patrizia Berto, PharmD, MBA, Senior Consultant, Analytica LASER, Milano, Italy Paul Swinburn, Masters, Senior Scientist, Evidera, London, UK Paul D'Amico, PhD, RN, NP, Director, Oncology Field Medical Group, Pfizer, Inc., Smithtown, NY, Pawel Kawalec, MD, PhD, Assistant Professor, Jagiellonian University Medical College, Krakow, Malopolska, Poland Pedro Plans-Rubio, MD, MSc, Resposible for Health Registries, Public Health Agency of Catalonia, Barcelona, Spain Pero Draganic, MD, PhD, Principal Advisor for Medicines and Pharmacoeconomics, Croatian Agency for Medicinal Products and Medical Devices, Zagreb, Croatia Peter Kaskel, MD, MBA, Senior Market Access Manager, MSD Sharp & Dohme GMBH, Haar, Munich/Bavaria, Germany Peter Mallow, PhD, Program Director, Health Economics, Market Access, & Reimbursement, Cardinal Health, Cincinnati, OH, Peter Schneider, Researcher, Austrian Public Health Institute, Vienna, Austria Pierluigi Vullo, BA, MSc, Managing Director, Semantics Medical Market Research, London, UK Pramit Nadpara, PhD, MS, BPharm, Assistant Professor, Virginia Commonwealth University School of Pharmacy, Richmond, VA, Pranay Wal, PhD, Dean Research and Development, Pranveer Singh Institute of Technology, Kanpur, Uttar Pradesh, India Prasanna Deshpande, PharmD, Assistant Professor, Bharati Vidyapeeth University, Pune, Maharashtra, India Prashant Sakharkar, PharmD, MPH, Assistant Professor, Roosevelt University College of Pharmacy, Schaumburg, IL, Praveen Gunda, MTech, Group Lead, Novartis, Hyderabad, Telangana, India Preeti Barnwal, PhD, Junior Research Fellow, Jamia Hamdard (Hamdard University), New Delhi, India Prerna Patel, MPH, MSc, Medical Writer/ PRO-QOL Researcher, Mapi Group, Mumbai, Maharashtra, India Prina Donga, MS, Teva Pharmaceuticals, Frazer, PA, Priyanka Ingle, MD, PhD, Translational Clinical Pharmacologist, CRC Pharma, Parsippany, NJ, Qaiser Iqbal, MPhil, Assistant Professor, University of Balochistan, Quetta, Balochistan, Pakistan Rachele Busca, PharmD, MSc, Director Reimbursement And Pricing Strategy, BTG, London, UK

17 Rafal Jaworski, MSc, Associate Director Market Access, MSD Poland, Warsaw, Mazovian Distr., Poland Rahul Dhanda, PhD, Director, Indivior, Richmond, VA, Rajasekhar Reddy Poonuru, PhD, Associate Professor, St. Peter's Institute of Pharmaceutical Sciences, Hanamkonda, Telangana, India Rajesh Balkrishnan, PhD, Professor, University of Virginia School of Medicine, Charlottesville, VA, Raju Kanukula, MPH, Research Assistant, The George Institute for Global Health, Hyderabad, India Rakesh Thode, MPharm, HEOR Analyst Level 1, Marksman Healthcare Solutions, Navi Mumbai, Maharashtra, India Ramesh Madhan, MPharm, PhD, Professor & Head, Department of Pharmacy Practice, JSS College of Pharmacy, JSS University, Mysuru, Karnataka, India Randa Eldessouki, MBBCH, MPH, MD, Assistant Professor Public Health, Fayoum University, Fayoum, Egypt Raymond Harvey, MPH, Research Lead, Comprehensive Health Insights, Avon, CO, Reem Assal, PhD, Lecturer of Pharmacoeconomics and Pharmacoepidemiology, German University in Cairo, Cairo, Egypt Rene Allard, PhD, Public Disclosure Lead, Grünenthal GmbH, Aachen, NRW, Germany Riad Dirani, PhD, Vice President, GHEOR, Teva Pharmaceuticals, Frazer, PA, Richard DeClue, MPH, PhD(c), Research Scientist, Comprehensive Health Insights, Humana Inc., Milwaukee, WI, Richard White, PhD, MPH, Senior Director, Celldes Therapudics, Hampton, NJ, Rituparna Basu, PhD, Senior Regional Reimbursement Economic Analyst, Medtronic, Mansfield, MA, Robert Bigelow, PhD, Associate Director, CT Statistics, Duke Clinical Research Institute, Durham, NC, Robert Hodgson, PhD, Research Fellow, University of York, York, North Yorkshire, UK Robert Babela, Head of Institute, St. Elisabeth University, Bratislava, Slovakia Roberto Palencia, MA, Senior Manager, Health Economics and Value, Merck KGaA, Darmstadt, Germany Roelien Postema, PharmD, Associate Director Worldwide HEOR, Bristol-Myers Squibb, Uxbridge, UK Roksana Hoque, MPH, Research Officer, Center for the Rehabilitation of the Paralyzed (CRP), Dhaka, Bangladesh, Savar, Bangladesh Ronda Copher, PhD, Director, Oncology HEOR, Eisai, Woodcliff Lake, NJ, Rose Mullen, PhD, MBA, RN, Medical Science Director, Alkermes, Waltham, MA, Rosina Hinojosa, MSc, MHE, President, ISPOR Peru, Lima, Peru Roy Moore, MBA, Principal Director, Global Market Access Insights, Decision Resources Group, Nashville, TN, Royce Burruss, RPh, MBA, Director Pharmacy, Cardinal Health Specialty Pharmacy, Columbia, MD, Ruchit Shah, PhD, Senior Research Analyst, Pharmerit International, Bethesda, MD, Rupert Gale, MA, Head Global Market Access, Respiratory, GSK, London, Middlesex, UK Russell Knoth, PhD, Director, Health Economics & Outcomes Research, Eisai, Inc., Woodcliff Lake, NJ, Ruth Rivas, Mexico, Mexico Sabrina Dieleman, MSc, Health Economics Coordinator, GSK, Bogotá, Cundinamarca, Colombia

18 Saibal Das, MD, PG Registrar, Christian Medical College, Vellore, Tamil Nadu, India Sally Elotla, PhD, Lecturer, Suez canal university, Ismaillia, Egypt Samantha Kurosky, MSPH, Director, Health Economics, RTI Health Solutions, Research Triangle Park, NC, Samir Ahid, PharmD, Pharmacologist, Mohammed V University, Rabat, Morocco Samuel Abariga, MD, MS, DTM&H, Research Associate, Evidera, Waltham, MA, Samuel Ampaabeng, PhD, Research Economist, IMPAQ International, LLC, Columbia, MD, Sandeep Kiri, MSc, Health Outcomes and HTA Lead, Eli Lilly UK, Basingstoke, Hampshire, UK Sandipan Bhattacharjee, BPharm, MS, PhD, Assistant Professor, The University of Arizona, Tucson, Arizona, Sandra Neubauer, DI, BSc, Scientist, Joanneum Research, Graz, Styria, Austria Sandra Nestler-Parr, MSc, MPhil, PhD, Head of Rare Diseases, Roboleo & Co, London, UK Sang-Eun Choi, PhD, Professor, Korea University, Sejong, South Korea Sang-Soo Lee, PhD, Corporate Affairs Director, Medtronic Korea Ltd., Seoul, South Korea Sanjay Patil, MPharm, PhD, Associate Professor, SNJB's Shriman Sureshdada Jain College of Pharmacy, Neminagar, Chandwad, Nashik, Maharashtra, India Sanjeev Balu, PhD, MBA, BPharm, Head, HEOR & RWE, Sandoz, Inc., Princeton, NJ, Santosh Agarwal, MS, MBA, Director, Healthcare Economics, Medtronic, Mansfield, MA, Sarah Shingler, BSc, MSc, Consultant, DRG Abacus, Oxford, Oxfordshire, UK Sarah Donelson, MA, Lead, Patient-Centered Research & Collaboration, Genentech, South San Francisco, CA, Saurabh Nagar, MS, BPharm, Health Outcomes Scientist, RTI Health Solutions, Durham, NC, Sayuri Shimizu, MSc, PhD, Senior Researcher, Institute for Health Economics and Policy, Minato- Ku, Tokyo, Japan Scott Charland, PharmD, Clinical health Outcomes Director, Sanofi US, Winter Park, CO, SeungJin Bae, ScD, Associate Professor, Ewha Womans University College of Pharmacy, Seoul, Korea Shaimaa Fouad, MSc, Deputy Director Of PE Unit, Pharmacoeconomics Unit, Egyptian Health and Population Ministry, Cairo, Egypt Shainur Premji, MSc, Senior Analyst, Alberta Health Services, Calgary, Alberta, Canada Shankar Prasad Nagaraju, DM, Associate Professor, Kasturba Medical College, Manipal University, Manipal, Karnataka, India Shanshan Sheehy, ScD, Assistant Professor, Boston University, Boston, MA, Sharanya Murty, MS, PhD, Manager, Xcenda Shekoufeh Nikfar, PhamD, PhD, Associate Professor, TUMS, Tehran, Tehran, Iran Shengsheng Yu, PhD, Global Market Access, Abbott, Alameda, CA, Shinichi Noto, PhD, Professor, Niigata University of Health and Welfare, Niigata, Niigata, Japan Shoeb Ahmed Ilyas, MPH, MPHIL, MHA, MHRM, MSc, Consultant, Ruby Med Plus, Hyderabad, Telangana, India Shyam Lohani, MPharm, PhD, RPH, Professor and Academic Director, Nobel College, Pokhara University, Kathmandu, Bagmati, Nepal Silke Walleser Autiero, MPH, Principal Reimbursement Analyst, Medtronic, Tolochenaz, Vaud, Switzerland Siva Narayanan, MS, MHS, PhD, Vice President & Global Head, Market Access, PTC Therapeutics, South Plainfield, NJ, Sizhu Liu, MS, Manager, Xcenda, Clarskburg, MD, Slaveyko Djambazov, MD, MBA, MPH, Medical University Pleven, Pleven, Bulgaria

19 Sohail, Ahmad, PharmD, MSc, Lecturer, Faculty of Pharmacy, Mahsa University, Kuala Langat, Selangor, Malaysia Somnath Pal, BS(Pharm), MS, MBA, PhD, Professor, St. John's University, Jamaica, NY, Song Wang, PhD, Health Economics & Outcomes Research Associate Director, Janssen Scientific Affairs, LLC, Horsham, PA, Sophi Tatlock, BA, Senior Research Manager, Adelphi Values, Bollington, Cheshire, UK Sophia Marsh, BPharm, MSc, UK Soumana Nasser, PharmD, Pharmacy Practice, Chairperson, Lebanese American University, Byblos, Lebanon Sreedhar Dharmagadda, PhD, Associate Professor & Head, Manipal College of Pharmaceutical Sciences, Manipal, Karnataka, India Srija Katta, PharmD, Student, St. Peter's Institute of Pharmaceutical Sciences, Hanamakonda, Telangana, India Stella Mokiou, MSc, PhD, Evidence-based Medicine and Outcomes Researcher, Merck Serono Ltd, London, UK Stephane Bouee, MD, MSc, Head of RWE Department, CEMKA, Bourg La Reine, France Stephane Roze, MSc, Chief Executive Officer, Heva HEOR, Lyon, Rhône-Alpes, France Stephane Soulard, Market Access Manager & HEOR Expert, Boehringer Ingelheim, Amsterdam, The Netherlands Stephanie Eaneff, MSP, Senior Data Scientist, PatientsLikeMe, Cambridge, MA, Stephen Stemkowski, MHA, PhD, Practice Leader, Comprehensive Health Insights, Louisville, KY, Stylianos Tsintzos, MD, MSc, Senior Manager - Global HEOR, Medtronic, Tolochenaz, Vaud, Switzerland Subhash Mandal, MPharm, PhD, Assistant Director, Drugs Control, Directorate of Drugs Control, Kolkata, West Bengal, India Sun Lee, PharmD, Health Outcomes Research Fellow, Western University of Health Sciences, Pomona, CA, Sunita Nair, PhD, Consultant, Self Employed, Mumbai, India Surabhi Dutta, MSc, Consultant, Eliassen Group, Annandale, NJ, Surrey Walton, PhD, Associate Professor, UIC, Chicago, IL, Susanne Bethge, PhD, Scientific Advisor, Innovation Committee at the Federal Joint Committee (Healthcare), Berlin, Germany Susi Ari Kristina, PhD, Lecturer, Universitas Gadjah Mada, Yogyakarta, Yogyakarta, Indonesia Suzanne Laplante, BPharm, MSc, DLSHTM, Health Economist, CADTH, Ottawa, ON, Canada Syed Umer Jan, PhD, Assistant Professor, University of Balochistan, Quetta, Balochistan, Pakistan Taehwan Park, PhD, Assistant Professor, St Louis College of Pharmacy, St Louis, MO, Tamas Agh, MD, MSc, PhD, Principal Researcher, Syreon Research Institute, Budapest, Hungary Tami Wisniewski, MPH, Lead, WWHEOR - Oncology, Bristol Myers-Squibb, Princeton, NJ, Tan Pham, MPH, MS, Biostatistician & PhD Candidate, Mapi/Northern Illinois University, Boston, MA, Tasneem Lokhandwala, BPharm, MS, PhD, Manager, Real-world Evidence, Xcenda, LLC, Tampa, FL, Tatiana Dilla, PhD, Head of Health Outcomes, Lilly, Madrid, Spain Teresa Lemmer, MSc, Health Economic and Outcomes Research Consultant, Evidencias - Kantar Health, São Paulo, Brazil Tessa Hartog, PhD, CMPP, Senior Manager HEOR Communications, Excerpta Medica, Amsterdam, NH, The Netherlands